Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
| Autor: | Arijit Mitra, Chandoshi Mukherjee, Peck Lin Lip, Samer Elsherbiny, N. Ajith Kumar |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
wet age-related macular degeneration
medicine.medical_specialty genetic structures posterior vitreous traction business.industry Angiogenesis pigment epithelial detachment Macular degeneration medicine.disease Article eye diseases Ophthalmology Wet age-related macular degeneration medicine Full-thickness macular hole Full thickness Intravitreal ranibizumab Ranibizumab Full thickness macular hole intravitreal ranibizumab injection business Macular hole medicine.drug |
| Zdroj: | The Open Ophthalmology Journal |
| ISSN: | 1874-3641 |
| DOI: | 10.2174/1874364101509010177 |
| Popis: | Ranibizumab is a monoclonal antibody fragment that inhibits angiogenesis by inhibiting vascular endothelial growth factor A, used as a treatment for patients with wet aged-related macular degeneration (ARMD). Adverse effects from intravitreal Ranibizumab injections are well recognised. Macular hole formation following Ranibizumab injection is a complication that has been recently reported in few case reports. We present a larger case series of five patients, who developed full thickness macular holes (FTMH) after intravitreal Ranibizumab injections for treatment of wet ARMD that we were aware of between 2009 and 2013. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|